Articles

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation

Dpt of Hematology, Medical Oncology, and Pneumology, University Medical Center, Mainz, Germany;
Dpt of Hematology, Medical Oncology, and Pneumology, University Medical Center, Mainz, Germany;
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Germany;
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Germany;
Oncology, Hematology and Bone Marrow Transplantation Unit, Klinikum Nord, Nürnberg, Germany;
Oncology, Hematology and Bone Marrow Transplantation Unit, Klinikum Nord, Nürnberg, Germany;
Department of Laboratory Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden;
First Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria;
Department of Hematology, University Hospital, Heinrich Heine University Düsseldorf, Germany;
Department of Hematology, University Hospital, Heinrich Heine University Düsseldorf, Germany;
Klinik f. Innere Medizin II, Abt. Haematol. und Internist. Onkologie, Univ.-Klinikum Jena, Germany;
Klinik f. Innere Medizin II, Abt. Haemmatol. und Internist. Onkologie, Univ.-Klinikum Jena, Germany;
Dpt of Hematology and Oncology, Univ. Medical Center Mannheim, Univ. of Heidelberg, Mannheim,Germany;
Dpt of Hematology and Oncology, Univ. Medical Center Mannheim, Univ. of Heidelberg, Mannheim,Germany;
Dpt of Hematology and Oncology, Univ. Medical Center Mannheim, Univ. of Heidelberg, Mannheim,Germany;
III. Medical Department, Hematology and Oncology, Klinikum rechts der Isar, TUM, Munich, Germany;
III. Medical Department, Hematology and Oncology, Klinikum rechts der Isar, TUM, Munich, Germany;
Innere Klinik, Tumorforschung, University Hospital Essen, Germany;
Innere Klinik, Tumorforschung, University Hospital Essen, Germany;
Dpt of Transplantation Surgery, University Medical Center of the JGU, Mainz, Germany;
Institute for Transfusion Medicine, University Hospital Essen, Germany;
Institute of Virology and Immunobiology, University Medical Center Würzburg, Germany;
Lophius Biosciences, Regensburg, Germany;
Lophius Biosciences, Regensburg, Germany;
Lophius Biosciences, Regensburg, Germany;
Lophius Biosciences, Regensburg, Germany;
Lophius Biosciences, Regensburg, Germany;
Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Germany;
Dpt of Internal Medicine III, Hematology and Oncology, University Medical Center Regensburg, Germany
Haematologica Early view Dec 26, 2019 https://doi.org/10.3324/haematol.2019.229252